UBS AM
KYTH

UBS AM’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

UBS AM’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,922
Closed -$894K – 2788
2015
Q3 		$894K Buy
11,922
+5,322
+81% +$398K ﹤0.01% 1769
2015
Q2 		$497K Buy
6,600
+2,300
+53% +$123K ﹤0.01% 2067
2015
Q1 		$216K Buy
+4,300
New +$180K ﹤0.01% 2451

UBS AM's KYTH Position: Q4 2015 in Review

UBS AM sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 11,922 shares — an estimated $894K sold.

UBS AM first reported a position in KYTH in Q1 2015 and held it in 3 quarters. The position peaked at $894K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • UBS AM reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • UBS AM sold 11,922 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $894K.
  • UBS AM first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2015 and held it in 3 quarters.
  • UBS AM's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $894K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on UBS AM's 13F filing for Q4 2015, filed 12 Feb 2016.